Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches ...

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist ...

A bumetanide nasal spray in development for heart failure was well-tolerated and showed reliable rates of absorption compared ...

This rainy weather plus the incoming holiday stress can trigger migraines. But there’s a brand new medicine available for ...